|
| 36595080 | [Triple-negative breast cancer : Classification, current concepts, and therapy-related factors]. | Pathologie (Heidelb) | 2023 |
| 37900552 | Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023. | Breast Care (Basel) | 2023 |
| 37900553 | AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023. | Breast Care (Basel) | 2023 |
| 37015943 | Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer. | Sci Rep | 2023 |
| 37014668 | Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial. | Clin Cancer Res | 2023 |
| 37005590 | Comparing gene expression in deep infiltrating endometriosis with adenomyosis uteri: evidence for dysregulation of oncogene pathways. | Reprod Biol Endocrinol | 2023 |
| 37302085 | Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy? | Breast Cancer Res Treat | 2023 |
| 36788095 | High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker. | Mod Pathol | 2023 |
| 36576522 | [Immunohistology in breast diagnostics : Strategies for efficient diagnostics]. | Pathologie (Heidelb) | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36635403 | [B3 lesions of the breast: histological, clinical, and epidemiological aspects : Update]. | Pathologie (Heidelb) | 2023 |
| 32657944 | Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. | Ann Surg | 2022 |
| 35481403 | Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks<sup>§</sup>. | Syst Biol Reprod Med | 2022 |
| 35469015 | Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. | Nat Cancer | 2022 |
| 36402755 | Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities. | Cell Death Dis | 2022 |
| 35999270 | Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature. | Br J Cancer | 2022 |
| 35933885 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model. | Eur J Cancer | 2022 |
| 35955851 | Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting. | Int J Mol Sci | 2022 |
| 36156915 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022. | Breast Care (Basel) | 2022 |
| 36156913 | AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022. | Breast Care (Basel) | 2022 |
| 34878635 | Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries? | Breast Cancer Res Treat | 2022 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 34581923 | Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients. | Ann Surg Oncol | 2022 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 32936950 | A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer. | Histopathology | 2021 |
| 33743484 | Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials. | Eur J Cancer | 2021 |
| 33822253 | [Relevant mutations in predictive breast cancer pathology]. | Pathologe | 2021 |
| 33846547 | Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup. | Mod Pathol | 2021 |
| 33593886 | Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer. | Clin Cancer Res | 2021 |
| 34469495 | Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial. | PLoS One | 2021 |
| 34720743 | Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update. | Geburtshilfe Frauenheilkd | 2021 |
| 34569185 | Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study. | Cancer Med | 2021 |
| 34248462 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021. | Breast Care (Basel) | 2021 |
| 34248463 | AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021. | Breast Care (Basel) | 2021 |
| 34036222 | CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer. | JCO Precis Oncol | 2021 |
| 34282521 | JUNB suppresses distant metastasis by influencing the initial metastatic stage. | Clin Exp Metastasis | 2021 |
| 33998175 | uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils. | EMBO Mol Med | 2021 |
| 33338758 | Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients. | Eur J Radiol | 2021 |
| 33418062 | Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>â¿¿</sup>. | Ann Oncol | 2021 |
| 33239449 | CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not Nephropathy. | Diabetes | 2021 |
| 32198421 | Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. | Nat Commun | 2020 |
| 31918324 | Statistical modelling of HER2-positivity in breast cancer: Final analyses from two large, multicentre, non-interventional studies in Germany. | Breast | 2020 |
| 31768620 | DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. | J Cancer Res Clin Oncol | 2020 |
| 31654190 | Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery. | Breast Cancer Res Treat | 2020 |
| 31912797 | Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. | Ann Oncol | 2020 |
| 32973084 | Chromothripsis in Human Breast Cancer. | Cancer Res | 2020 |
| 32634256 | Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancer. | Histopathology | 2020 |
| 32737030 | Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma. | Clin Cancer Res | 2020 |
| 32899175 | Immunohistological Expression of SOX-10 in Triple-Negative Breast Cancer: A Descriptive Analysis of 113 Samples. | Int J Mol Sci | 2020 |
| 32923902 | Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A-Type Breast Cancer. | JCO Precis Oncol | 2020 |